申请人:——
公开号:US20040259917A1
公开(公告)日:2004-12-23
Imidazole compounds substituted directly, or by a bridge, with a heteroaryl moiety containing N adjacent to the point of connection of the heteroaryl, are mGluR5 modulators useful in the treatment of psychiatric and mood disorders such as, for example, schizophrenia, anxiety, depression, bipolar disorder and panic, as well as in the treatment of pain, circadian rhythm disorders, and other diseases.
直接或通过桥连接取代咪唑化合物,其杂环芳基团中含有与杂环芳基连接点相邻的N,是mGluR5调节剂,可用于治疗精神和情绪障碍,例如精神分裂症、焦虑、抑郁、双相情感障碍和恐慌,以及治疗疼痛、昼夜节律紊乱和其他疾病。